Stay updated on MK-3475 and Gemcitabine in NSCLC Clinical Trial
Sign up to get notified when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.

Latest updates to the MK-3475 and Gemcitabine in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed an older government funding status notice; these are administrative updates that do not affect the study details or data presented on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedResults First Posted and Results Posted entries with dates were added, along with a PDF link to the Study Protocol and Statistical Analysis Plan. A government funding status notice was added, and an older 'Frequency of Toxicities' entry was removed.SummaryDifference2%

- Check28 days agoChange DetectedAdded a 'Show glossary' option and updated footer metadata to include 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with Revision: v3.4.0. Removed the older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive content changes to the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section now includes Oregon; Oregon Locations removed. The page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe page now shows 'Results Submitted' instead of 'No Results Posted' and the revision is updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to MK-3475 and Gemcitabine in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MK-3475 and Gemcitabine in NSCLC Clinical Trial page.